Phoenix Lending Survey Results Shows a Shift in the Outlook of the U.S. Economy

PHILADELPHIA, PA—(Marketwired – October 12, 2017) – From the third quarter Phoenix Management “Lending Climate in America” Survey, results shows a marked shift in lenders outlook on the U.S. economy in both the near and long term.

The Q3 2017 survey results reversed the recent trend of expectations for the near term GPA to be higher than the long term GPA. Lenders optimism on how they expect the U.S. economy to perform beyond the next 6 months increased 22 points from a 2.30 in the previous quarter to 2.52. On the contrary, their expectation on how they expect the U.S. economy to perform in the near term continued to decrease, falling 7 points to a 2.43 in Q3 2017 from the Q2 2017 GPA of 2.50.

Furthermore, lenders were surveyed on what they believe will be the outcome on the near term economy if President Trump were to cut taxes and increase infrastructure spending. Contrary to their increasing pessimistic view on the near term economy, 52% of lenders believe that there would be a positive outcome — additional spending, financed cheaply given the current interest rate environment, if taxes were cut and infrastructure spending increased.

In addition, lenders were also surveyed regarding the economic factors they believe will have the strongest potential to affect the near–term economy. Fifty–five percent of respondents believe unstable energy prices will have the strongest impact on the economy in the next six months, while forty–five percent of lenders surveyed believe that the stability of the stock market will have the strongest potential to affect the U.S. economy in the near–term.

The sentiment for unstable energy prices is further supported by the fact that many lenders (66%) believe that we will immediately see the biggest effect on domestic gasoline prices due to major shutdowns experienced during hurricanes Harvey and Irma. Of the lenders surveyed, 17% believe that we will see the biggest effect on domestic gasoline prices in a) Q3 2017, and b) Q4 2017 from hurricanes Harvey and Irma.

“Lenders are anticipating dramatic reductions in loan losses and bankruptcy filings during the next 6 months. Lenders confidence on the health of the U.S. economy in the near term continues to decrease slightly but remains relatively stable. However, we have seen a significant increase in their confidence in the U.S. economy in the longer term which is a positive indication for 2018,” says Michael Jacoby, Senior Managing Director and Shareholder of Phoenix.

To see the full results of Phoenix's “Lending Climate in America” Survey, please visit

About Phoenix:

For over 30 years, Phoenix has provided smarter, operationally focused solutions for middle market companies in transition. Phoenix Management Services® provides turnaround, crisis and interim management, specialized advisory and operational implementation services for both distressed and growth oriented companies. Phoenix Transaction Advisory Services® provides quality of earnings, management/organizational review, business integration, sell–side business preparation and other transaction related support. Phoenix Capital Resources® provides seamless investment banking solutions including M&A advisory, complex restructurings and capital placements. Phoenix Capital Resources is a U.S. registered broker–dealer and member of FINRA and SIPC. Proven. Results.®

If you would like to learn more about Phoenix, please visit or

Image Available:–5d396df069a5bff391377a63de428e8f.JPG

Psoriatic Arthritis' Impact Not Always Visible or Understood, Patients Say

PHILADELPHIA, PA—(Marketwired – October 12, 2017) – Explaining the “invisible” aspects of psoriatic arthritis often presents a challenge, according to “Psoriatic Arthritis In America,” a newly released Health Union survey of patients diagnosed with the condition.

Survey respondents said they often experience difficulty in making others understand that despite a lack of outwardly visible symptoms, they have a chronic condition that can cause fatigue and affects their entire body.

Psoriatic arthritis (PsA) is an inflammatory disease closely related to and most often co–occurring with psoriasis. The most commonly reported symptom among respondents was fatigue (94 percent), but other symptoms include pain, swelling and stiffness of the joints, and inflammation and pain of ligaments and tendons at attachment points.

Seventy–three percent of patients said they had experienced flares at least monthly, with flares lasting several weeks. Those experiencing frequent (i.e., daily or weekly) flares described the condition as “painful,” “frustrating,” and “debilitating.”

The survey found 68 percent reporting PsA had an impact on their overall quality of life, with 75 percent of respondents indicating it had negatively affected their ability to exercise or participate in physical activity, while 56 percent reported a negative effect on their ability to work.

“I'm not the person I once was, and I miss her,” wrote one anonymous respondent. “I miss her optimism and laughter. It is truly heartbreaking.”

Survey data also shows many respondents saw several healthcare providers (HCPs) before receiving an official PsA diagnosis, with one in four seeing two and nearly the same amount (24 percent) requiring three. Seven percent said they needed to visit 10 or more HCPs before receiving a diagnosis.

Of those respondents diagnosed with PsA, 64 percent were also diagnosed with psoriasis, with most (73 percent) receiving the psoriasis diagnosis first. Additionally, 52 percent of those with psoriasis reported living with the autoimmune skin condition for more than a decade before receiving a PsA diagnosis.

A desire for more information was a common theme among those surveyed, with 78 percent saying they wished they had known more at the time of their PsA diagnosis about all the symptoms psoriatic arthritis can cause, how psoriatic arthritis would affect their lifestyle (77 percent), or the impact psoriatic arthritis would have on mental, as well as physical health (75 percent).

“We see a recurring theme — a desire for people with PsA to have more information about the condition and its impact — in our 'Psoriatic Arthritis In America' surveys,” said Health Union CEO and Co–founder Olivier Chateau, “which is why it is important to have an online community like Psoriatic– where people can share their experiences, learn from one another, and find information on the latest treatments.”

“Psoriatic Arthritis In America” surveyed 1,033 U.S. patients and was conducted May 22 through July 9, 2017.

A summary infographic of the results is available and additional details about the survey can be provided upon request.

About Health Union, LLC and Psoriatic–

Health Union inspires people to live better with challenging health conditions — combining new, original content every day with digital, social and mobile technologies to cultivate active online health communities. Health Union platforms are unique ecosystems dedicated to illuminating the voices and experiences of people with psoriatic arthritis (PsA), rheumatoid arthritis, type 2 diabetes, and more. Its services and offerings foster open and honest interactions about these health conditions between and among patients, caregivers, professionals, providers and industry partners to help all stakeholders make more informed decisions about healthcare. Psoriatic– is Health Union's online community dedicated to people living with PsA, where patients and supporters of people living with this condition can connect, share experiences, and learn about managing the condition.

Image Available:–e8be9493aef793ddaa757c6a490e1363.jpg

Realm Therapeutics Announces Completion of $26 million Private Placement

MALVERN, PA—(Marketwired – Oct 12, 2017) – Realm Therapeutics plc (AIM: RLM), a clinical stage biopharmaceutical company focused on leveraging its proprietary immunomodulatory technology, announces that the private placement of $26 million (the “PIPE”) that it previously disclosed on September 21, 2017, was approved by its shareholders at a general meeting held in London on October 9, 2017 and has been completed today. The 66,396,485 new ordinary shares issued by the Company in the PIPE were admitted to trading on AIM, a market operated by the London Stock Exchange, on October 10, 2017. US and UK healthcare specialist funds that participated in the PIPE included OrbiMed, BVF Partners LP, RA Capital Management, Abingworth BioEquities Master Fund Ltd and Polar Capital.

Realm Therapeutics plc   +44 (0) 20 3727 1000
Alex Martin, Chief Executive Officer    
Marella Thorell, Chief Financial Officer and Chief Operating Officer    
FTI Consulting   +44 (0) 20 3727 1000
Simon Conway / Mo Noonan    
N+1 Singer (Nominated Adviser and Broker)   +44 (0) 20 7496 3000
Aubrey Powell / Lauren Kettle    

About Realm Therapeutics

Realm Therapeutics is a clinical–stage biopharmaceutical company focused on developing novel immunomodulatory therapies to protect and improve the lives of adults and children. The Company has initiated drug development programs, based on its proprietary hypochlorous acid technology at high concentrations. The Company believes its formulations have novel immunomodulatory activity with potential application for the treatment of diseases in a number of therapeutic areas, including Dermatology and Ophthalmology. 


The securities described herein have not been and, except as provided in a registration rights agreement with the PIPE purchasers in respect thereof, will not be registered under the U.S. Securities Act of 1933 and, accordingly, any offer or sale of the securities in the United States or to U.S. persons may be made only in a transaction exempt from the registration requirements of the Securities Act unless and until they are registered for sale in the United States. This release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any jurisdiction on which such offer or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.

Aliat Universidades Selects D2L's Brightspace to Modernize Its Teaching and Learning Experiences

MEXICO CITY, MEXICO—(Marketwired – October 12, 2017) – D2L, a global learning technology leader, today announces that Aliat Universidades has selected its Brightspace learning management system (LMS) for its 3,500 teachers and 45,000 students.

Aliat is a network of 27 Mexican universities based in Mexico City. It has a presence in 15 Mexican states and offers a variety of programs, degrees, specializations, master's programs and doctorate programs. The universities comprising this network have a proven, successful track record and are recognized for their academic quality.

The Aliat network includes Universidad Tangamanga, Universidad ETAC, Universidad La Concordia, Universidad de Estudios Avanzados and Universidad Valle del Grijalva. They serve a population of working adults and young students.

Aliat first started using D2L's adaptive learning platform, Brightspace LeaP™, in 2016 to personalize learning. After having such a successful experience with LeaP, they began exploring using Brightspace to curate content from the best universtities around the world. They decided to implement Brightspace across its 27 campuses this year, and the intent is to enable multidisciplinary and multigeographic integration so students across different schools can interact with each other from any level and campus.

“One of our goals is to teach all our students how to use Brightspace as it provides tools that will make them more competitive in the workplace. Brighstpace is enabling us to migrate the academic, student, and teachers community to the digital world and we are striving to reach 100 percent adoption,” said Yael Villicaña Garciamoreno, Corporate Director of Academic Development, Aliat Universidades. “We are confident that Brightspace will enable us to improve our entire teaching and learning experience, and will be a great success in our education community,” concluded Yael Villicaña.


Aliat Universidades offers educational services that provide access to a quality professional education relevant to the social, political and economic development of Mexico while fostering in its students a well–rounded development, concern for humanity and social commitment to others. Aliat Universidades seeks to establish itself as the leading network of private universities in the country promoting the education of competent professionals who stand out through rapid job placement, sensitivity to social needs, transformation of their surroundings, love of country and a sense of ethics.


D2L's Brightspace is a learning management system (LMS) that helps schools and institutions deliver personalized learning in a classroom or online to people anywhere in the world. Created for the digital learner, Brightspace is cloud–based, runs on mobile devices, and offers rich multimedia to increase engagement, productivity and knowledge retention. The platform makes it easy to design courses, create content and grade assignments, giving instructors more time to focus on what's most important: greater teaching and learning. At the same time, analytics reports track and deliver insights into the performance levels of departments, courses or individuals.

Brightspace was recently named the #1 LMS in Higher Ed by Ovum Research and #1 in Adaptive Learning by eLearning Magazine. In addition, the Fosway Group recognized Brightspace on its 9–Grid™ Analysisfor corporate buyers of HR, talent and learning solutions in the EMEA market. Aragon Research included Brightspace in its highly coveted Hot Vendors In Learning list.


D2L is the software leader that makes the learning experience better. The company's cloud–based platform is easier to use, more flexible and smart. With Brightspace, companies can personalize the experience for every learner to deliver real results. The company is a world leader in learning analytics: its platform predicts learner performance so that companies can take action in real–time to keep employees on track. Brightspace is used by learners in higher education, K–12 and the enterprise sector, including the Fortune 1000. D2L has operations in the United States, Canada, Europe, Australia, Brazil and Singapore.

© 2017 D2L Corporation.

The D2L family of companies includes D2L Corporation, D2L Ltd, D2L Australia Pty Ltd, D2L Europe Ltd, D2L Asia Pte Ltd and D2L Brasil Soluções de Tecnologia para Educação Ltda. All D2L marks are trademarks of D2L Corporation. Please visit for a list of D2L marks.

All D2L marks are trademarks of D2L Corporation. Please visit for a list of D2L marks.